Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1089332716 | 10893327 | 16 | F | 20150203 | 20160830 | 20150306 | 20160906 | EXP | DE-ACTELION-A-US2015-114153 | ACTELION | 39.00 | YR | A | F | Y | 0.00000 | 20160907 | OT | DE | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1089332716 | 10893327 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK | 21779 | INHALATION VAPOUR, SOLUTION | |||||||||
| 1089332716 | 10893327 | 2 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK, TID | 21779 | INHALATION VAPOUR, SOLUTION | TID | ||||||||
| 1089332716 | 10893327 | 3 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 4 TIMES A DAY | 21779 | INHALATION VAPOUR, SOLUTION | |||||||||
| 1089332716 | 10893327 | 4 | C | WARFARIN | WARFARIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1089332716 | 10893327 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1089332716 | 10893327 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1089332716 | 10893327 | Abdominal discomfort | |
| 1089332716 | 10893327 | Anaemia | |
| 1089332716 | 10893327 | Anxiety | |
| 1089332716 | 10893327 | Cough | |
| 1089332716 | 10893327 | Depressed mood | |
| 1089332716 | 10893327 | Depression | |
| 1089332716 | 10893327 | Dizziness | |
| 1089332716 | 10893327 | Fear of disease | |
| 1089332716 | 10893327 | Haemoptysis | |
| 1089332716 | 10893327 | Influenza | |
| 1089332716 | 10893327 | Nasopharyngitis | |
| 1089332716 | 10893327 | Peripheral swelling | |
| 1089332716 | 10893327 | Pneumonitis | |
| 1089332716 | 10893327 | Product use issue | |
| 1089332716 | 10893327 | Productive cough | |
| 1089332716 | 10893327 | Pyrexia | |
| 1089332716 | 10893327 | Quality of life decreased | |
| 1089332716 | 10893327 | Tooth disorder | |
| 1089332716 | 10893327 | Vomiting | |
| 1089332716 | 10893327 | Walking distance test abnormal | |
| 1089332716 | 10893327 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1089332716 | 10893327 | 1 | 20080901 | 0 |